Race to stop deadly bleeding after birth: scientists test new drug delivery methods
NCT ID NCT05370820
Summary
This study aims to find the best dose and method (IV or injection) to give a drug called tranexamic acid (TXA) to prevent severe bleeding after childbirth. Researchers are enrolling about 120 pregnant women to test how the drug moves through the body when given in different ways just before delivery. The goal is to gather data to help doctors use this preventive treatment more effectively in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST PARTUM HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
George Washington University Hospital
RECRUITINGWashington D.C., District of Columbia, 20037, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Inova Fairfax Medical Campus
RECRUITINGFalls Church, Virginia, 22042, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.